Center Affiliation and Expertise: Inflammation and Innate Immunity
Dr. Weiner’s laboratory studies lymphoma immunotherapy in general, with a recent focus on monoclonal antibody-based therapy and use of TLR9 agonists as components of combination immunotherapy. In addition, Dr. Weiner serves as Director of the Holden Comprehensive Cancer Center, a position he has held for the past 15 years. He has served, and currently serves in a number of national leadership roles related to cancer centers. He is the President of the Association of American Cancer Institutes, and was former chair of NCI subcommittee A (known as the cancer center parent committee). He chairs the External Advisory Boards for 4 NCI designated cancer centers, and serves on 5 other cancer center EABs. He is Vice-chair of the Science Policy and Governmental Affairs Committee of the American Association for Cancer Research. He has also served as PI of the Iowa/Mayo Lymphoma SPORE P50 grant for the past 13 years and has an active research laboratory exploring novel approaches to cancer immunotherapy.